Healthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan Africa

BACKGROUND: Mortality from cryptoccocal meningitis remains high. The ACTA trial demonstrated that, compared with 2 weeks of amphotericin B (AmB) plus flucystosine (5FC), 1 week of AmB and 5FC was associated with lower mortality and 2 weeks of oral flucanozole (FLU) plus 5FC was non-inferior. Here, w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Infect Dis
Hauptverfasser: Chen, Tao, Mwenge, Lawrence, Lakhi, Shabir, Chanda, Duncan, Mwaba, Peter, Molloy, Síle F, Gheorghe, Adrian, Griffiths, Ulla K, Heyderman, Robert S, Kanyama, Cecilia, Kouanfack, Charles, Mfinanga, Sayoki, Chan, Adrienne K, Temfack, Elvis, Kivuyo, Sokoine, Hosseinipour, Mina C, Lortholary, Olivier, Loyse, Angela, Jaffar, Shabbar, Harrison, Thomas S, Niessen, Louis W
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2019
Schlagworte:
Articles and Commentaries
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6669289/
https://ncbi.nlm.nih.gov/pubmed/30863852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy971
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge